Patient Safety: Proactive Management and Detection of Hepatotoxicity in Prevention of Drug Induced Liver Injury Andrew Botham, PhD, Head of R&D ACM Global Central Laboratory
by ACM Global Central Laboratory on Mar 30, 2012
- 527 views
In many clinical trial scenarios, there may only be one chance to collect, ship, test and analyze a patient's specimen. These often time-sensitive snapshots into a patient's progression in a study are critical not only to the overall study results, but ultimately the safety of patients undergoing treatment.
The lifecycle of a specimen, which starts at collection and ends at database lock, can be prone to human error along each step of the testing process, particularly when conducting global clinical trials in more remote ends of the world. Sponsors need to ensure the integrity of the specimen throughout this process, while balancing the relative cost of logistics.
Based on lessons learned from managing global clinical trials testing, ACM Global Lab and its partners will share their insights on monitoring and oversight on patient safety, safeguarding sample integrity, and good business sense.
- Total Views
- Views on SlideShare
- Embed Views